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Insulin- and leptin-stimulated phosphatidylinositol-3
kinase (PI3K) activation has been demonstrated to
play a critical role in central control of energy ho-
meostasis. To delineate the importance of pathways
downstream of PI3K specifically in pro-opiomelano-
cortin (POMC) cell regulation, we have generated mice
with selective inactivation of 3-phosphoinositide-
dependent protein kinase 1 (PDK1) in POMC-express-
ing cells (PDK1DPOMC mice). PDK1DPOMC mice initially
display hyperphagia, increased body weight, and im-
paired glucose metabolism caused by reduced hypo-
thalamic POMC expression. On the other hand,
PDK1DPOMC mice exhibit progressive, severe hypo-
cortisolism caused by loss of POMC-expressing corti-
cotrophs in the pituitary. Expression of a dominant-
negative mutant of FOXO1 specifically in POMC cells
is sufficient to ameliorate positive energy balance
in PDK1DPOMC mice but cannot restore regular pitui-
tary function. These results reveal important but
differential roles for PDK1 signaling in hypothalamic
and pituitary POMC cells in the control of energy
homeostasis and stress response.
INTRODUCTION
Pro-opiomelanocortin (POMC)-expressing neurons are of critical
importance for control of food intake, energy expenditure, and
glucose metabolism (Cowley et al., 2001; Parton et al., 2007).
TheprohormonePOMC iscleaved intoa-melanocyte-stimulating
hormone (a-MSH), which, when secreted, binds to the melano-
cortin 3 and4 receptors (MC3RandMC4R)onsecond-order neu-
rons, some of which are located in the paraventricular nucleus of
the hypothalamus (Coll et al., 2004). MC4R activation decreases
food intake and increases energy expenditure, and MC4R ago-
nists provide a potential avenue for treatment of obesity. Con-
versely, mutations in the POMC or MC4R genes cause massive
early-onset obesity in humans, further supporting a crucial rolefor melanocortins in energy homeostasis (Farooqi et al., 2000;
Krude et al., 1998). Alternative cleavage of POMC results in
b-endorphin production, which also decreases food intake
independently of MC4R signaling (Appleyard et al., 2003).
POMC expression, POMC neuron firing, and thus ultimately a-
MSH release are under tight control of peripheral hormones such
as leptin and insulin, as well as nutrients such as glucose (Ko¨nner
et al., 2007; Mercer et al., 1996; Parton et al., 2007; Pinto et al.,
2004). Leptin signals by activating the signal transducer and
activator of transcription 3 (Stat3), which activates POMC ex-
pression by recruiting histone acetylases to the POMC promoter
(Kitamura et al., 2006). Concomitantly, leptin increases the firing
rate of POMCneurons by activating nonspecific cation channels,
although the exact molecular mechanisms mediating this effect
have yet to be fully elucidated (Cowley et al., 2001). Leptin stim-
ulation also leads to phosphatidylinositol-3 kinase (PI3K) activa-
tion in POMC neurons, and the acute anorectic effect of intracer-
ebroventricularly applied leptin can be inhibited by PI3K inhibitor
pretreatment (Niswender et al., 2001).
Pharmacological inhibition of PI3K in the central nervous
system also prevents the acute anorectic effect of centrally ad-
ministered insulin, although the cell type responsible for this
effect has yet to be identified (Niswender et al., 2003). In POMC
neurons, insulin strongly activates PI3K (Plum et al., 2006; Xu
et al., 2005). Surprisingly, this leads to accumulation of the
PI3K product phosphatidylinositol 3,4,5-trisphosphate (PIP3),
subsequent PIP3-mediated opening of ATP-dependent potas-
sium (KATP) channels, and thus electrical silencing of POMC neu-
rons (Plum et al., 2006). Moreover, leptin is not able to overcome
the hyperpolarization induced by insulin. Accordingly, chronic
activation of PI3K by deletion of the PIP3 phosphatase PTEN
leads to diet-sensitive hyperphagia and obesity (Plum et al.,
2006). On the other hand, deletion of the PTEN gene in all
leptin-responsive neurons as characterized by the expression
of ObRb results in enhanced sympathetic innervation of white
adipose tissue (WAT), leading to transdifferentiation of WAT to
brown adipose tissue (Plum et al., 2007).
Besides controlling KATP channel activation, presumably via
generation of PIP3, which directly binds the KATP channel, PI3K
activation leads to phosphorylation and activation of the down-
stream kinase AKT, which upon activation translocates to theCell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc. 291
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factor FOXO1. In the absence of PI3K activation, FOXO1 is
thought to negatively affect POMC transcription by recruitment
of histone deacetylases (Kim et al., 2006; Kitamura et al.,
2006). Thus, there is an apparent contradiction in that both acti-
vation and inhibition of PI3K in POMC neurons result in positive
energy balance. Nevertheless, the effect of reduced PI3K signal-
ing in POMC neurons has not been directly addressed.
POMC is also expressed in two specialized cell types in the
pituitary, namely corticotrophs in the anterior lobe and melano-
trophs in the intermediate lobe. Inmelanotrophs,POMCiscleaved
into a-MSH, which when released into circulation binds to the
MC1R on melanocytes of the skin to control pigmentation
(Rees, 2003). In corticotrophs, POMC is cleaved into adrenocorti-
cotrophic hormone (ACTH). Expression and release of ACTH is
stimulated by stress stimuli and, upon stimulation of MC2R on
the adrenal gland, increases synthesis and release of the steroids
corticosterone in rodents and cortisol in humans (Bornstein and
Chrousos, 1999; Dallman, 1984; Simpson and Waterman, 1988).
Cortisol hasmanyeffects; notably, it can induce insulin resistance,
stimulate food intake, and increase body weight, whereas a lack
of circulating cortisol leads to increased leptin and melanocortin
sensitivity, anorexia, weight loss, and impaired stress tolerance
(Drazen et al., 2003; Jacobson, 1999). Accordingly, restoration
of physiologic corticosterone concentrations in POMC knockout
mice, which have no circulating corticosterone due to failure of
adrenal gland development, leads to even more pronounced hy-
perphagia and obesity compared with unrestored POMC knock-
out mice (Smart et al., 2006).
The role of PI3K in corticotrophs and melanotrophs is poorly
understood. In vitro data indicate that inhibition of PI3K induces
apoptosis in pituitary tumor cell lines partially via regulation of the
proapoptotic Zac1 gene. Neither chronic PI3K activation nor de-
letion of the insulin receptor on corticotrophs affects pituitary ar-
chitecture or stress response in vivo (Ko¨nner et al., 2007; Pagotto
et al., 1999; Plum et al., 2006; Theodoropoulou et al., 2006).
Although there are multiple isoforms of regulatory and cata-
lytic subunits of PI3K, only one isoform of 3-phosphoinositide-
dependent protein kinase 1 (PDK1) has been identified thus
far (Alessi et al., 1997; Williams et al., 2000). PDK1 is recruited
to the cell membrane by PIP3 and, among multiple other targets,
phosphorylates AKT, thereby activating it. Thus, to address the
effect of kinase signaling downstream of PI3K on energy homeo-
stasis and stress response in vivo, we generated mice lacking
PDK1 selectively in POMC-expressing cells (PDK1DPOMC) using
Cre/loxP-mediated recombination.
RESULTS
Generation of PDK1DPOMC Mice
To achieve this goal, we crossed mice transgenic for Cre driven
by the POMC promoter (POMC-Cre+/) with mice carrying the
floxed PDK1 allele (PDK1flDneo/flDneo). Mice heterozygous for
both alleles were crossed to PDK1flDneo/flDneo mice. We thereby
generated mice homozygous for the loxP-flanked PDK1 allele
that also carried the POMC-Cre transgene (genotype POMC-
Cre+/:PDK1flDneo/flDneo), i.e., PDK1DPOMC mice. Littermates of
PDK1DPOMC mice negative for Cre, genotype PDK1flDneo/flDneo,
were usedas controls. Additionally, weascertained that thepres-292 Cell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc.ence of the POMC-Cre bacterial artificial chromosome had no
effect on body weight, as shown previously (see Figure S1A
available online) (Balthasar et al., 2004; Lawlor et al., 2002). To
visualize POMC cell-specific Cre-mediated recombination, we
used two reporter mouse strains that express enhanced GFP
or b-galactosidase (lacZ) only after Cre-mediated recombination.
Double immunohistochemical analysis of lacZDPOMC mice re-
vealed the presence of immunoreactive PDK1 protein in 70%
of lacZ-positive POMC neurons of lacZDPOMC animals but in
only 8% of lacZ-positive POMC neurons of lacZ:PDK1DPOMC
mice, indicating that PDK1 deletion occurred with 90% effi-
ciency in POMC-expressing cells (Figures 1A and 1B). As
expected, since POMC neurons make up only a very small pro-
portion of the hypothalamus, immunoblot analyses of control
and PDK1DPOMC mice showed no difference in PDK1 protein
content in lysates obtained from total brain or peripheral tissues
(Figure 1C). Similarly, deletion of the PDK1 allele was only found
in DNA extracts from the arcuate nucleus of the hypothalamus
and the pituitary, where POMC is expressed, but not in the hippo-
campus or peripheral tissues (Figure 1D).
To assess whether PDK1 deficiency affects hypothalamic
POMC cell differentiation and/or survival, we quantified the num-
ber of hypothalamic GFP-positive POMC cells in control GFP
reporter animals (GFPDPOMC) and GFP reporter animals lacking
PDK1 in POMC cells (PDK1:GFPDPOMC) both in young mice at
the age of 4 weeks and in older mice at the age of 12 weeks.
This analysis revealed no difference in the total number of
POMC neurons between control and PDK1DPOMC mice (Figures
1E and 1F).
Hyperpolarization of POMC Neurons
by Insulin Is PDK1 Independent
Next, we performed electrophysiological analyses of GFP-posi-
tive neurons from GFPDPOMC and GFP:PDK1DPOMC reporter
mice. Although the resting membrane potential of POMC neu-
rons lacking PDK1 was slightly depolarized, there was no signif-
icant difference between control and knockout reporter neurons
regarding spontaneous firing rate, membrane resistance, or
capacitance, the latter of which is also an indirect measure of
neuron size (Figures 2A–2D).
We then tested the response to insulin, which in POMC neu-
rons induces opening of KATP channels, resulting in hyperpolar-
ization and a consequent reduction of the firing rate (Plum et al.,
2006). Insulin stimulation significantly hyperpolarized GFP-posi-
tive neurons of GFPDPOMC and GFP:PDK1DPOMC reporter mice
and robustly reduced their firing rate (Figure 2E). As in control
POMC neurons, incubation with the KATP channel blocker tolbu-
tamide restored firing rate in POMC neurons of GFP:PDK1DPOMC
reporter mice (Figure 2F). Taken together, these findings indicate
that insulin-stimulated POMC cell hyperpolarization is PI3K
dependent but PDK1 independent, consistent with a model in
which PIP3 directly activates KATP channels in POMC neurons.
Increased Body Weight and Hyperphagia
in Young PDK1DPOMC Mice
To investigate whether PI3K activation in POMC neurons plays
another PDK1-dependent role in energy homeostasis, we mon-
itored body weight of control and PDK1DPOMC mice fed either
a normal chow diet (ND) or a high-fat diet (HFD). Shortly after
Cell Metabolism
POMC Cell-Specific PDK1 KnockoutFigure 1. Specificity of PDK1 Deletion in
PDK1DPOMC Mice
(A) Detection of PDK1 in POMC neurons by
immunohistochemistry. Using lacZDPOMC and
lacZ:PDK1DPOMC reporter mice, coimmunohisto-
chemistry for b-galactosidase and PDK1 was
performed, and the number of POMC cells stain-
ing positive for PDK1 was counted for at least
100 neurons from two mice per genotype. Red,
lacZ (POMC neurons); green, PDK1; blue, DAPI.
Original magnification, 3630.
(B) Quantification of PDK1 expression in POMC
neurons from lacZDPOMC and lacZ:PDK1DPOMC
mice.
(C)Western blot analysis of PDK1 and IR-b subunit
expression (loading control) in hypothalamus (HYP),
whole brain (BRAIN), liver (LIVER), skeletal muscle
(SM), and pancreas (Panc) of PDK1flDneo/flDneo and
PDK1DPOMC mice (n = 4 per group).
(D) Detection of deletion of the PDK1 allele in
PDK1DPOMC mice. DNA was extracted from the
arcuate nucleus (ARC), hippocampus (HIP), pitui-
tary (PIT), liver (LIV), adrenal gland (AG), skeletal
muscle (SM), heart (HRT), white adipose tissue
(WAT), and kidney (KID) of a PDK1DPOMC mouse.
Using a PCR strategy, the deleted allele could be
detected only in the arcuate nucleus and the pitu-
itary, but not in the other tissues (upper bands).
(E) POMC cell counts in the arcuate nucleus of
GFP reporter mice showed no difference between
GFPDPOMC and PDK1:GFPDPOMC reporter mice at
4 and 12 weeks of age (n = 3 per genotype at
each age). Results are expressed as number of
neurons staining positive for GFP.
(F) Cre-mediated recombination was visualized
by immunohistochemistry for GFP in brains of
GFPDPOMC and PDK1:GFPDPOMC mice. Represen-
tativesections forGFPDPOMCandPDK1:GFPDPOMC
mice are shown. Scale bars = 50 mm.
Displayed values are means ± SEM. *p < 0.05.weaning, male and female PDK1DPOMC mice fed either diet
presented slightly but significantly increased body weight (Fig-
ures 3A and 3B; Figures S1B and S1C). However, body weight
of control and PDK1DPOMC mice converged over time (Figures
3A and 3B). Consistent with the increased body weight of young
PDK1DPOMC mice, these animals also exhibited elevated serum
leptin and glucose concentrations at 8 weeks of age (Figures
3C and 3D). To address whether the initially increased body
weight of PDK1DPOMC mice resulted from increased energy
intake, we determined food intake in these mice at 8 weeks of
age, which revealed significant hyperphagia (Figure 3F).
Analysis of hypothalamic neuropeptide expression in
PDK1flDneo/flDneo and PDK1DPOMC mice revealed a significant
reduction in POMC expression in the absence of any alteration in
the expression of the orexigenic neuropeptides agouti-relatedpro-
tein (AgRP) and neuropeptide Y (NPY) as well as the thyrotropin-
releasing hormone (TRH) (Figure 3G; Figure S2A). Taken together,
these data indicate that PDK1DPOMC mice initially develop tran-
siently increased body weight as a consequence of hyperphagia
caused by reduced hypothalamic POMC expression.
Since the body weight of male PDK1DPOMC mice was not
distinguishable from that of PDK1flDneo/flDneo mice starting at 10
weeks of age, we next determined parameters of energy homeo-stasis in older mice. Surprisingly, food intake of PDK1DPOMC
mice was not significantly different from controls at 10 weeks
of age (Figure 3F). Strikingly, at 18 weeks of age, PDK1DPOMC
mice exhibited significantly reduced epigonadal fat-pad mass
and lower serum leptin concentration but unchanged body
weight (Figures 3D and 3E). Hypothalamic expression of NPY,
AgRP, and TRH was again unchanged (Figure S2A) at 18 weeks
of age, while hypothalamic POMC expression was still reduced
by 80% in PDK1DPOMC mice compared to controls (Figure 3G).
Thus, progressive reduction of body weight, food intake, serum
leptin concentration, and epigonadal fat-pad mass occurred
in the presence of constantly reduced hypothalamic POMC
expression.
Secondary Hypocortisolism in PDK1DPOMC Mice
Given the paradoxical decline of initially increased body weight
and hyperphagia in the presence of constantly repressed
POMC transcription, we decided to investigate possible mecha-
nismsunderlying thisphenotype.Wenoticed thatoldPDK1DPOMC
mice performed better than control mice during glucose toler-
ance tests and showed significantly increased insulin sensitivity
during insulin tolerance tests (Figure S1D). Moreover, analysis
of glucose-stimulated insulin secretion revealed that althoughCell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc. 293
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PDK1flDneo/flDneo mice, their blood glucose concentration was
significantly lower than in control groups, further corroborating
the finding that PDK1DPOMC mice exhibit dramatically increased
peripheral insulin sensitivity and subsequent compensatory
reduction of insulin secretion (Figures S1E and S1F). Taken to-
gether, the relative body weight loss and dramatically increased
insulin sensitivity in older mice resemble key clinical features of
severe hypocortisolism (Jacobson, 1999).
Strikingly, analysis of plasma corticosterone concentrations
revealed a significant reduction in PDK1DPOMC mice compared
to control mice at as early as 3 weeks of age, and importantly,
corticosterone concentrations further decreased over time in
PDK1DPOMC mice (Figure 4B). Moreover, analysis of stress-
induced corticosterone release revealed that PDK1DPOMC
mice exhibited a dramatic impairment in stress-induced corti-
costerone production (Figure 4A; Figure S1G). Similarly, injec-
tion of an ACTH analog in PDK1DPOMC mice could not increase
plasma corticosterone to the level of control mice, consistent
with adrenal insufficiency (Figure 4C). Taken together, these
data indicate that PDK1DPOMC mice exhibit critically reduced
Figure 2. Hyperpolarization of POMC
Neurons by Insulin Is PDK1 Independent
(A) Spontaneous firing rate of identified POMC
neurons in ARC slices fromGFPDPOMC (n = 30 neu-
rons) and GFP:PDK1DPOMC (n = 12 neurons) mice.
(B) Mean resting membrane potential of identified
POMC neurons in ARC slices from GFPDPOMC
(n = 30 neurons) and GFP:PDK1DPOMC (n = 12 neu-
rons) mice.
(C) Mean membrane resistance of identified
POMC neurons in ARC slices from GFPDPOMC
(n = 30 neurons) and GFP:PDK1DPOMC (n = 12 neu-
rons) mice.
(D) Mean membrane capacitance of identified
POMC neurons in ARC slices from GFPDPOMC
(n = 25 neurons) and GFP:PDK1DPOMC (n = 11 neu-
rons) mice.
(E) Firing frequency and membrane potential of
identified POMC neurons in ARC slices from
GFPDPOMC and GFP:PDK1DPOMC mice before
and after application of 200 nM insulin (n = 6–7
neurons per group).
(F) Representative recordings of identified POMC
neurons in ARC slices from a GFPDPOMC and
a GFP:PDK1DPOMC mouse before and 15 min after
200 nM insulin stimulation, followed by addition of
200 mM tolbutamide.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01; n.s., not significant.
circulating corticosterone with further
progressive loss into adulthood.
Hypothalamic corticotrophin-releasing
hormone (CRH) is partially responsible
for POMC expression and ACTH release
from the pituitary after stress stimuli, but
not under basal conditions, as CRH
knockout mice show no change in basal
pituitary POMC expression (Muglia
et al., 2000). There was no difference in hypothalamic CRH
expression between PDK1flDneo/flDneo and PDK1DPOMC mice at
any age or on any diet, indicating that hypothalamic circuits
are not responsible for the loss of circulating corticosterone in
PDK1DPOMC mice (Figure S2A).
As changes in the function of corticotrophs of the pituitary
were likely responsible for hypocortisolism in PDK1DPOMC
mice, we next examined the pattern of GFP expression in the
pituitary of GFPDPOMC mice and GFP:PDK1DPOMC mice. This
analysis revealed a greater than 90% reduction in GFP-positive
corticotroph numbers in GFP:PDK1DPOMC mice compared to
GFPDPOMC mice (Figures 4D and 4E). Consistent with the dra-
matic reduction in corticotroph number, real-time PCR analysis
revealed an 80% reduction of pituitary POMC mRNA expres-
sion in PDK1DPOMC mice compared to PDK1flDneo/flDneo mice
(Figures 4F and 4G). We also noted a dramatic decrease in
melanotroph numbers in the intermediate lobe of the pituitary,
but, in accordance with the notion that even POMC knockout
mice have a relatively faint change in pigmentation and fur color,
we did not notice any obvious change in the fur color or skin pig-
mentation of PDK1DPOMCmice (data not shown). Taken together,294 Cell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc.
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of corticotrophs and that POMC cell-restricted PDK1 deficiency
results in secondary hypocortisolism. Thus, our study reveals
that PDK1 plays critical but divergent roles in POMC-expressing
cell types: while PDK1 deficiency in hypothalamic POMC neu-
rons affects POMC transcription and not cell survival, it primarily
controls cell survival of corticotrophs and melanotrophs in the
pituitary.
Corticosterone Replacement Prolongs Hyperphagia
and Increased Body Weight in PDK1DPOMC Mice
To directly address whether progressive hypocortisolism con-
tributes to the normalization of hyperphagia and increased
bodyweight of PDK1DPOMCmice, we next aimed to restore circu-
lating corticosterone concentrations in PDK1DPOMCmice. To this
end, we implanted osmotic minipumps filled with corticosterone
in 8-week old mice and monitored corticosterone concentra-
tions, body weight, and food intake. One week after surgery,
circulating corticosterone levels were similar between
Figure 3. Increased Body Weight, Hyper-
phagia, and Reduced Hypothalamic POMC
Expression in PDK1DPOMC Mice
(A) Average body weight of male PDK1flDneo/flDneo
(,) and PDK1DPOMC (-) mice on normal diet
(ND) (n = 16–20).
(B) Average body weight of male PDK1flDneo/flDneo
(,) and PDK1DPOMC (-) mice on high-fat diet
(HFD) (n = 12–24).
(C) Blood glucose levels in 8-week-old female
PDK1flDneo/flDneo (left white bar, n = 17), female
PDK1DPOMC (left black bar, n = 17), male
PDK1flDneo/flDneo (right white bar, n = 21) and
male PDK1DPOMC (right black bar, n = 16) mice.
(D) Serum leptin concentrations of male
PDK1flDneo/flDneo (white bars, n = 17–20) and
PDK1DPOMC (black bars, n = 10–13) mice at 8
and 18 weeks of age.
(E) Epigonadal fat-pad weight and body weight in
male PDK1flDneo/flDneo (white bars, n = 21) and
PDK1DPOMC (black bars, n = 13) mice on ND at
18 weeks of age.
(F) Daily food intake inmale PDK1flDneo/flDneo (white
bars, n = 13, 5) and PDK1DPOMC (black bars, n = 7,
4) mice on ND at 8 weeks and 10–11 weeks of age.
(G) POMC and AgRP expression in male
PDK1flDneo/flDneo (white bars, n = 5–11) and
PDK1DPOMC (black bars, n = 5–11) mice on ND at
8 and 18 weeks of age as measured by real-time
PCR.
(H) Hypothalamic POMC expression in male
PDK1flDneo/flDneo (white bars, n = 4–5) and
PDK1DPOMC (black bars, n = 4–5) mice on ND or
HFD at 18 weeks of age as measured by real-
time PCR.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01.
PDK1flDneo/flDneo mice and PDK1DPOMC
mice (Figure 5A). Two weeks after sur-
gery, food intake and body weight were
significantly increased in PDK1DPOMC
mice (Figures 5B and 5C), at a timewhere
there is no significant difference between unrestored
PDK1DPOMC mice and control mice (Figures 3A and 3F). More-
over, epigonadal fat-pad mass was significantly increased in
PDK1DPOMC mice 3 weeks after surgery (Figure 5D). Taken to-
gether, these data demonstrate that corticosterone restoration
aggravates positive energy balance in PDK1DPOMCmice, indicat-
ing that in unrestored PDK1DPOMCmice, the effect of reduced hy-
pothalamic POMC expression is ameliorated by progressive loss
of circulating corticosterone.
Restoration of Energy Homeostasis in PDK1DPOMC
Mice by FOXO1 Inhibition In Vivo
Next, we aimed to define the pathways that act downstream of
PDK1 to regulate hypothalamic POMC expression and/or corti-
cotroph survival in the pituitary. Many kinases and transcription
factors act downstream of PDK1, notably AKT, mTOR, S6K1,
SGK1, and PKC isoforms, and thus could contribute to the ob-
served phenotype (Mora et al., 2004). Yet one of the major medi-
ators of PI3K signaling is the transcription factor FOXO1. FOXO1Cell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc. 295
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implicated in the control of POMC transcription (Kim et al.,
2005, 2006; Kitamura et al., 2006; Medema et al., 2000). As
FOXO1 phosphorylation and exclusion from the nucleus are
AKT dependent, cells lacking PDK1 have increased FOXO1 ac-
tivity. Therefore, we aimed to generate a mouse line with Cre-in-
ducible expression of a dominant-negative FOXO1 (FOXO1D256)
mutant that lacks the transactivation domain and the nuclear
export signal (Figure S3) (Nakae et al., 2001). Expression of
FOXO1D256 leads to its accumulation in the nucleus, where
it binds to FOXO1 cis-elements and inhibits binding of endoge-
nous FOXO1 protein, thus precluding transactivation. We
crossed FOXO1D256 mice with PDK1DPOMC mice to generate
FOXO1D256:PDK1DPOMC mice, which lack PDK1 specifically in
POMC-expressing cells but express FOXO1D256 at the same
time.
Figure 4. Reduced Plasma Corticosterone
and Adrenal ACTH Insensitivity in
PDK1DPOMC Mice
(A) Plasma corticosterone levels of male
PDK1flDneo/flDneo (white bars, n = 6) and
PDK1DPOMC (black bars, n = 5) mice on ND before
and after a stress test at 12 weeks of age.
(B) Basal plasma corticosterone levels in male
PDK1flDneo/flDneo (white bars, n = 7–10) and
PDK1DPOMC (black bars, n = 5–9) mice at 3, 4,
and 5 weeks of age.
(C) Plasma corticosterone levels in PDK1flDneo/flDneo
(white bars, n = 5) and PDK1DPOMC (black bars,
n = 5) mice after intraperitoneal injection of saline
or an ACTH analog (Synacthen) at 12 weeks of
age.
(D) Immunohistochemistry for GFP from pituitary
sections of GFPDPOMC and GFP:PDK1DPOMC
mice at approximately 12 weeks of age. Brown,
horseradish peroxidase (GFP). Single cortico-
trophs are marked by arrows.
(E) Quantification of GFP-positive corticotrophs
from pituitary sections of GFPDPOMC (white bar,
n = 2) and GFP:PDK1DPOMC (black bar, n = 3) mice.
(F) Immunohistochemistry for ACTH from pituitary
sections of PDK1flDneo/flDneo and PDK1DPOMC mice
at approximately 8 weeks of age. Green, ACTH. At
least three mice of each genotype were analyzed.
Original magnification, 3100.
(G) Relative pituitary POMC expression in female
and male PDK1flDneo/flDneo (white bars, n = 5–6)
and PDK1DPOMC (black bars, n = 4–6) mice on
ND or HFD at 18 weeks of age as measured by
real-time PCR.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001.
Since the mRNA encoding the
FOXO1D256 mutant also codes for GFP
protein, which is translated from an inter-
nal ribosome entry site (IRES), GFP
immunohistochemistry can identify cells
expressing the FOXO1D256 mutant (Fig-
ure S3). Hypothalamic GFP-posi-
tive cell counts were similar between
FOXO1D256:PDK1DPOMC, GFP:PDK1DPOMC, and GFP DPOMC re-
porter mice at 4 or 12 weeks of age, indicating appropriate ex-
pression of the FOXO1D256 mutant protein without an effect on
POMC neuron number (Figure 1E; Figures 6A and 6B).
Because young PDK1DPOMC mice showed increased body
weight and hyperphagia, we next analyzed Cre-negative
PDK1flDneo/flDneo, FOXO1D256:PDK1flDneo/flDneo, PDK1DPOMC,
and FOXO1D256:PDK1DPOMC littermates with regards to energy
homeostasis. Body weight of FOXO1D256:PDK1flDneo/flDneo and
PDK1flDneo/flDneo mice was indistinguishable; thus, animals of
both genotypes were combined into the control group (called
PDK1Cre). While PDK1DPOMC mice showed significantly in-
creased body weight compared to control littermates,
expression of FOXO1D256 restored normal body weight in
FOXO1D256:PDK1DPOMC mice (Figure 6C). Similarly, FOXO1D256
expression prevented hyperphagia in PDK1DPOMC mice296 Cell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc.
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POMC Cell-Specific PDK1 KnockoutFigure 5. Corticosterone Restoration Main-
tains Hyperphagia and Increased Body
Weight in PDK1DPOMC mice.
(A) Plasma corticosterone concentration in
PDK1flDneo/flDneo (white bars) and PDK1DPOMC
(black bars) mice before and after implantation of
a corticosterone minipump. Animals were bled at
8 weeks of age, and surgery was performed imme-
diately afterwards. Corticosterone levels were
measured 1 and 2 weeks after surgery (n = 7–12
per genotype).
(B) Body weight of PDK1flDneo/flDneo (white bars)
and PDK1DPOMC (black bars) mice before and after
corticosterone minipump implantation (n = 7–12
per genotype).
(C) Daily food intake of PDK1flDneo/flDneo (white
bars) and PDK1DPOMC (black bars) mice before
and after corticosterone minipump implantation
(n = 7–12 per genotype).
(D) Epigonadal fat-pad mass of PDK1flDneo/flDneo
(white bars) and PDK1DPOMC (black bars) mice at
the end of corticosterone restoration (3 weeks
after surgery; n = 7–10).
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001.(Figure 6D). Moreover, while blood glucose concentrations in
PDK1DPOMC mice were significantly increased compared to
PDK1Cre animals, there was no difference between PDK1Cre
and FOXO1D256:PDK1DPOMC mice (Figure S4A). Strikingly, while
hypothalamic POMC expression was significantly decreased in
PDK1DPOMCmice compared to PDK1Cremice, therewas no sig-
nificant difference between control and FOXO1D256:PDK1DPOMC
mice (Figure 6E). Consistent with earlier observations, we no-
ticed a strong tendency toward decreased expression of the
anorexigenic neuropeptide cocaine- and amphetamine-related
transcript (CART) in PDK1DPOMC mice, which was completely
rescued in FOXO1D256:PDK1DPOMC mice (Figure 6E) (Kim et al.,
2006). Overall, these in vivo findings indicate that regulation of
FOXO1 activity in hypothalamic POMC neurons is the principal
means by which PDK1 signaling controls energy homeostasis.
Corticotroph Loss in PDK1DPOMC Mice
Is FOXO1 Independent
To investigate the effect of FOXO1D256 expression in cortico-
trophs, we performed stress tests in FOXO1D256:PDK1DPOMC
mice. FOXO1D256:PDK1DPOMC mice had reduced basal and
stress-induced corticosterone levels, similar to PDK1DPOMC
mice (Figure S1G). GFP and ACTH staining of pituitaries from
FOXO1D256:PDK1DPOMCmice showed the same reduction in cor-
ticotrophs as seen in PDK1DPOMCmice, and POMCexpression in
the pituitaries was again significantly reduced in 8-week-old
mice (Figures S4B and S4C).
To gain better insights into the dynamics of corticotroph loss,
we analyzed gene expression patterns in pituitaries of 3-week-
oldmice.POMCmRNAexpressionwasalreadycritically reduced
at this age in both PDK1DPOMC and FOXO1D256:PDK1DPOMCmice
(Figure 6F). We also assessed expression of growth hormone-
releasing hormone receptor (GHRHR) and thyroid-stimulating
hormone b subunit (TSHb), but we found no difference between
the different genotypes, indicating that the thyroid axis as wellas the general pituitary architecture is not affected in PDK1DPOMC
mice (data not shown). Strikingly, we found significantly in-
creased expression of the proapoptotic genes Bax and Bak
inPDK1DPOMCmice, but not in FOXO1D256:PDK1DPOMCmice (Fig-
ure 6F). Moreover, only PDK1DPOMC mice, but not FOXO1D256:
PDK1DPOMC mice, exhibited a tendency toward increased ex-
pression of the proapoptotic gene Zac1, which has been shown
to be under negative control of PI3K in pituitary cells in vitro
(Theodoropoulou et al., 2006) (Figure 6F). Taken together, our
data present direct in vivo evidence for important roles of
PDK1-dependent signaling in control of pituitary corticotroph
andmelanotroph function.While increased expression of several
proapoptotic genes in pituitaries of PDK1DPOMC mice can be
rescued by expression of FOXO1D256, survival of corticotrophs
appears to depend on one or more additional PDK1-dependent,
FOXO1-independent pathways.
DISCUSSION
The results of the current study reveal multiple, differential, and
important roles for PDK1 signaling in POMC cells. They demon-
strate in vivo that PI3K/PDK1/FOXO1-dependent signaling is
required for hypothalamic POMC transcription and that impaired
activation of this pathway results in hyperphagia and increased
body weight (Figure 7). Indeed, we demonstrate that mice
exposed to HFD exhibit a significant reduction in POMC expres-
sion compared to ND-exposed mice (Figure 3H). In late stages
of obesity, hypothalamic leptin and insulin resistance due to
increased SOCS3 expression and JNK activation have been
reported (Bjorbaek et al., 1998; De Souza et al., 2005; Kievit
et al., 2006); moreover, direct inhibition of hormone signaling
by nutrients such as fatty acids has also been reported (Pocai
et al., 2006). This would suggest that, in the presence of inhibited
insulin and/or leptin stimulation and thus AKT activation, FOXO1
may constantly repress POMCexpression, reducing the ability ofCell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc. 297
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POMC Cell-Specific PDK1 KnockoutFigure 6. Expression of FOXO1D256 Res-
cues the Hypothalamic Phenotype of
PDK1DPOMC Mice
(A) Cre-mediated recombination was visualized
using immunohistochemistry for GFP in brains of
GFPDPOMC and FOXO1D256:PDK1DPOMC mice.
Brown, horseradish peroxidase (GFP). Scale bar =
100 mm.
(B) POMC cell counts in the arcuate nucleus of GFP
reporter mice showed no difference between
GFPDPOMC (whitebars) andFOXO1D256:PDK1DPOMC
reporter (red bars) mice at 4 and 12 weeks of age
(n = 3 per genotype at each age). Results are ex-
pressed as number of neurons staining positive for
GFP.
(C) Average body weight of male PDK1Cre (white
boxes, n = 19), PDK1DPOMC (black boxes, n = 15)
and FOXO1D256:PDK1DPOMC (red boxes, n = 8)
mice on ND until 8 weeks of age. *p < 0.05
between control and PDK1DPOMC; **p < 0.01 be-
tween control and PDK1DPOMC; #p < 0.05 between
PDK1DPOMC and FOXO1D256:PDK1DPOMC.
(D) Food intake of male PDK1Cre (white bar,
n = 9), PDK1DPOMC (black bar, n = 10), and
FOXO1D256:PDK1DPOMC (red bar, n = 7) mice on
ND at 8 weeks of age.
(E) Relative expression of hypothalamic POMC
and CART mRNA in male PDK1Cre (white bars,
n = 17), PDK1DPOMC (black bars, n = 15), and
FOXO1D256:PDK1DPOMC (red bars, n = 7) mice on
ND at 8 weeks of age as measured by real-time
PCR.
(F) Relative expression of POMC and proapoptotic
genes in pituitary extracts from male PDK1Cre
(white bars, n = 8), PDK1DPOMC (black bars,
n = 11), and FOXO1D256:PDK1DPOMC (red bars,
n = 4) mice at 3 weeks of age as determined by
real-time PCR.
Displayed values are means ± SEM. Unless stated
otherwise: *p < 0.05; **p < 0.01; ***p < 0.001;
n.s., not significant.POMC neurons to release a-MSH during obesity. In fact, Enriori
et al. (2007) have demonstrated impaired a-MSH release in HFD-
exposed mice.
On the other hand, in the earlier stages of obesity, insulin and
leptin levels are increased, leading to initially increased PI3K
activation. Our previous work has revealed that enhanced acti-
vation of PI3K signaling specifically in POMC cells results in hy-
perphagia, due to neuronal silencing as a consequence of KATP
channel opening in the presence of increased POMC transcrip-
tion. Here we demonstrate that this effect is directly mediated
by PIP3-dependent, PDK1-independent KATP channel activation
(Figure 7). Taken together, these studies demonstrate a tightly
regulated dynamic range of the PI3K signaling pathway in control
of energy homeostasis: both initially enhanced insulin action as
occurs early in overfeeding and also insulin and leptin resistance
as present later in the development of obesity lead to POMC cell
dysfunction. Although mechanistically different, the biological
outcome, namely hyperphagia and weight gain is the same.
Thus, pharmacological manipulation of the PI3K pathway in
POMC cells must carefully restore signaling in the optimal range
(Figure 7).298 Cell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc.Moreover, we clearly demonstrate a pivotal role for PDK1
signaling in POMC cell survival in the pituitary. The mechanism
underlying this phenomenon appears to be complex. Previous
in vitro experiments on cultivated adenoma cells had already
indicated a role for PI3K/PDK1-dependent regulation of Zac1
in control of somatotroph and corticotroph cell survival (Pagotto
et al., 1999; Theodoropoulou et al., 2006). This seems not to be
the only PI3K/PDK1-dependent pathway responsible for POMC
cell survival in the pituitary in vivo, since increased expression of
proapoptotic genes such as Bax, Bak, and Zac1 can be restored
by expression of FOXOD256 in vivo without rescuing pituitary
POMC cell survival. Further experiments unraveling the exact
nature of this pathway may help to design novel therapeutic
interventions for pituitary corticotroph adenomas.
The integrative view of the hypothalamic and pituitary pheno-
type of PDK1DPOMC mice also highlights the impact of POMC
gene dosage on energy homeostasis. While humans and mice
null for both POMC alleles are hyperphagic and obese in the
absence of circulating cortisol/corticosterone, humans hetero-
zygous for one POMC null allele exhibit a predisposition for
increased body weight and obesity (Farooqi et al., 2006; Krude
Cell Metabolism
POMC Cell-Specific PDK1 Knockoutet al., 1998; Yaswen et al., 1999). Moreover, we show that the
relatively small effect of severely reduced hypothalamic POMC
expression in PDK1DPOMC mice on food intake and obesity is
caused by the pronounced loss of circulating corticosterone,
as restoration of corticosterone leads to sustained hyperphagia,
weight gain, and increased fat mass at an age at which unre-
stored PDK1DPOMC mice do not show any difference in food in-
take and body weight compared to control mice. Nonetheless,
the notion that b-endorphin and other POMC neuropeptides in
the pituitary may affect the overall phenotype of PDK1DPOMC
mice cannot be completely ruled out at this point.
It is also conceivable that POMC neurons use compensatory
signals to decrease food intake and energy expenditure inde-
pendently of POMC expression and a-MSH release, for example
the neurotransmitters glutamate and GABA (Collin et al., 2003;
Hentges et al., 2004). Althoughwe noticed a significant reduction
in POMC neuron membrane potential by an as yet unknown
mechanism, it is unlikely that this has an effect on overall neuron
function, as all other electrophysiological parameters, including
firing rate, were unchanged. Additionally, residual PDK1 expres-
sion in a very small percentage of POMC neurons may also at-
tenuate the effect of PDK1 loss in themajority of POMC neurons.
Moreover, we observed a small subpopulation of POMCneurons
Figure 7. Model of PI3K- and Stat3-Dependent Pathways in POMC
Neurons
Activation of phosphatidylinositol-3 kinase (PI3K) in POMC neurons results in
moderate AKT activation leading to phosphorylation of the transcription factor
FOXO1. Phosphorylated FOXO1 is excluded from the nucleus, allowing for
POMC transcription. At the same time, normal activation of PI3K results in
the opening of only a fewKATP channels, which enables leptin-dependent firing
of the POMC neuron and leptin-dependent stimulation of POMC transcription
by signal transducer and activator of transcription 3 (Stat3), as FOXO1 is ex-
cluded from the nucleus and cannot block POMC transcription. IR, insulin re-
ceptor; IRS, insulin receptor substrate; PDK1, 3-phosphoinositide-dependent
protein kinase 1; FOXO1, forkhead box O1; PIP3, phosphatidylinositol 3,4,5-
trisphosphate; K+, potassium cation.that do not seem to express PDK1 at all. Previous studies re-
ported that leptin and insulin fail to stimulate a small percentage
of POMC neurons, possibly because these neurons lack the
leptin and insulin receptors or downstream signal cascademem-
bers, indicating that there are several subpopulations of POMC
neurons (Choudhury et al., 2005). Thus, the present study under-
lines the complex regulation of cellular and molecular pathways
in control of energy balance and reveals important, cell-type-




All animal care was within University of Cologne institutional animal care com-
mittee guidelines. All animal procedures were conducted in compliance with
protocols approved by local government authorities (Bezirksregierung Ko¨ln,
Cologne, Germany) and were in accordance with National Institutes of Health
guidelines. Mice were housed in groups of three to five at 22C–24C with a
12 hr light/12 hr dark cycle. Animals were fed either a normal chow diet (ND;
Teklad Global Rodent 2018, Harlan) containing 53.5% carbohydrate, 18.5%
protein, and 5.5% fat (12% of calories from fat) or a high-fat diet (HFD;
C1057, Altromin) containing 32.7% carbohydrate, 20% protein, and 35.5%
fat (55.2% of calories from fat). Animals were given ad libitum access to water
at all times, and food was only withdrawn if required for an experiment. Body
weight was measured once per week, and nasoanal body length was mea-
sured before sacrifice. Genotyping was performed by PCR using genomic
DNA isolated from tail tips as described previously (Lawlor et al., 2002).
Mice were sacrificed using CO2.




mice. The background was unchanged throughout all experiments. Littermates
were used for all analyses except reporter mouse studies. The stated pheno-
types of the PDK1DPOMC mice were stable for more than five generations.
Generation of FOXO1D256 Mice
We generated a ROSA26 locus targeting vector in which CAGS promoter-
driven expression of the FOXO1D256 mutant and IRES-GFP is inhibited by
a loxP-flanked stop cassette. This vector was transfected into F1 embryonic
stem (ES) cells, which were screened for correct integration by standard
Southern blot methods. Correctly targeted ES cells were used to generate
chimeras, which were backcrossed on a C57/BL6 background and examined
for germline transmission. All FOXO1D256:PDK1DPOMC mice were heterozy-
gous for the FOXO1D256 transgene.
Analytical Procedures
Blood glucose values were determined from whole venous blood using an au-
tomatic glucose monitor (GlucoMen, A. Menarini Diagnostics). Serum insulin,
leptin, and plasma corticosterone were measured by ELISA using mouse
standards according to the manufacturer’s guidelines (Rat Insulin ELISA,
#INSKR020, Crystal Chem Inc.; Mouse Leptin ELISA, #90030, Crystal Chem
Inc.; Corticosterone EIA Kit, #900-097, Assay Designs).
Western Blotting
Indicated tissues were dissected and homogenized in homogenization buffer
with a polytron homogenizer (IKAWerke), and western blot analyses were per-
formed by standard methods with antibodies raised against IR-b (#sc-711,
Santa Cruz) and PDK1 (#611070, BD Biosciences) as described previously
(Gropp et al., 2005; Janoschek et al., 2006).
Corticosterone Replacement
Before surgery, dexamethasone (5 mg/kg body weight) was injected intraper-
itoneally to prevent death as a consequence of stress arising from surgery inCell Metabolism 7, 291–301, April 2008 ª2008 Elsevier Inc. 299
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POMC Cell-Specific PDK1 KnockoutPDK1DPOMCmice. Osmoticminipumps (model 2004, Alzet) prefilledwith 10 mg/
ml corticosterone were implanted in anaesthetized mice according to the man-
ufacturer’s instructions. Blood was taken every week between 2 and 4 p.m.
Mice that did not show a significant increase in plasma corticosterone were
dismissed from the study.
Statistical Methods
Data were analyzed for statistical significance by two-tailed unpaired Stu-
dent’s t test unless indicated otherwise. Neuronal firing-rate data were ana-
lyzed for statistical significance by Mann-Whitney rank sum test.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
four figures and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/7/4/291/DC1/.
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